Osalmid Inhibits the Progression of Lung Adenocarcinoma and Sensitizes It to EGFR-TKIs: A Preclinical and Translational Study

被引：0
|
作者：
Wu, L. -L. [1 ]
Jiang, W. -M. [1 ]
Wang, R. -R. [2 ]
Xie, D. [2 ]
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[2] Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.03I.14
引用
收藏
页码：S315 / S315
页数：1
相关论文
共 50 条
  • [1] Management of diarrhea induced by EGFR-TKIs in advanced lung adenocarcinoma
    Cardenas-Fernandez, Daniela
    Soberanis Pina, Pamela
    Turcott, Jenny G.
    Chavez-Tapia, Norberto
    Conde-Flores, Emilio
    Cardona, Andres F.
    Arrieta, Oscar
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [2] Prognostic Factors in Lung Adenocarcinoma with Bone Metastasis Treated with EGFR-TKIs
    Chiu, Tzu-Hsuan
    Lin, Chun-Yu
    Hsieh, Meng-Heng
    Lin, Shu-Min
    Fang, Yueh-Fu
    MEDICINA-LITHUANIA, 2021, 57 (09):
  • [3] EGFR-TKIs compared with radiotherapy for patients of stage IV lung adenocarcinoma with EGFR mutation
    Wang, Y.
    Yu, W.
    Shi, J.
    Qiu, M.
    Jiang, N.
    Wang, Z.
    Yang, J.
    Song, M.
    Jia, Z.
    ANNALS OF ONCOLOGY, 2021, 32 : S976 - S976
  • [4] THE RESISTANCE TO EGFR-TKIS IN LUNG CANCER
    Yamada, T.
    Yano, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 77 - 77
  • [5] Evaluating the Efficacy of EGFR-TKIs Combined With Radiotherapy in Advanced Lung Adenocarcinoma Patients With EGFR Mutation: A Retrospective Study
    Wang, Yuxiang
    Yu, Wenjuan
    Shi, Jian
    Qiu, Rong
    Jiang, Nan
    Wang, Zhuofan
    Yang, Jie
    Jia, Zhongfei
    Song, Meng
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [6] Role of GPER1 in the Mechanism of EGFR-TKIs Resistance in Lung Adenocarcinoma
    Li, Zhenhua
    Pan, Yaqiang
    Liu, Qinghua
    Wang, Jian
    Liu, Chang
    Qu, Laihao
    Li, Dingbiao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] PD-L1 Induced Resistance to EGFR-TKIs in Lung Adenocarcinoma
    Yi, G.
    Zhang, X.
    Li, S.
    Liu, L.
    Yuan, P.
    Yang, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S629 - S629
  • [8] Effectiveness of EGFR-TKIs in a Patient with Lung Adenocarcinoma Harboring an EGFR-RAD51 Fusion
    Guan, Yan
    Song, Zhanshuai
    Li, Yan
    Guog, Honglin
    Shi, Junping
    Zhang, Xuemei
    Yao, Ming
    ONCOLOGIST, 2019, 24 (08): : 1027 - 1030
  • [9] The influence of tumor heterogeneity on sensitivity of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIs
    Sun, Li
    Li, Yao-Yong
    Ma, Jie-Tao
    Zhang, Shu-Ling
    Huang, Le-Tian
    Han, Cheng-Bo
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (05) : 1834 - 1844
  • [10] The content of mutant EGFR DNA correlates with response to EGFR-TKIs in lung adenocarcinoma patients with common EGFR mutations
    Hung, Ming-Szu
    Lung, Jr-Hau
    Lin, Yu-Ching
    Fang, Yu-Hung
    Hsieh, Meng-Jer
    Tsai, Ying-Huang
    MEDICINE, 2016, 95 (26)
12345